The Journal of Nutritional Biochemistry
Volume 21, Issue 8 , Pages 757-763 , August 2010

The role of epoxidation and electrophile-responsive element-regulated gene transcription in the potentially beneficial and harmful effects of the coffee components cafestol and kahweol

  • Saskia T.J. van Cruchten

      Affiliations

    • Department of Human Nutrition, Wageningen University, 6700 EV, Wageningen, The Netherlands
    • Top Institute of Food and Nutrition, 6709 PA, Wageningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Division of Human Nutrition, 6703 HD Wageningen, The Netherlands. Tel.: +31 0 317 480403; fax: +31 0 317 483342.
    • ,
  • Laura H.J. de Haan

      Affiliations

    • Department of Toxicology, Wageningen University, Wageningen, The Netherlands
    • ,
  • Patrick P.J. Mulder

      Affiliations

    • RIKILT, - Institute of Food Safety, 6700 EA, Wageningen, The Netherlands
    • ,
  • Cindy Kunne

      Affiliations

    • Liver Center, Academic Medical Center, 1105 BK, Amsterdam, The Netherlands
    • ,
  • Mark V. Boekschoten

      Affiliations

    • Department of Human Nutrition, Wageningen University, 6700 EV, Wageningen, The Netherlands
    • Top Institute of Food and Nutrition, 6709 PA, Wageningen, The Netherlands
    • ,
  • Martijn B. Katan

      Affiliations

    • Institute of Health Sciences, VU University Amsterdam, 1081 HV, Amsterdam, The Netherlands
    • ,
  • Jac M.M.J.G. Aarts

      Affiliations

    • Department of Toxicology, Wageningen University, Wageningen, The Netherlands
    • ,
  • Renger F. Witkamp

      Affiliations

    • Department of Human Nutrition, Wageningen University, 6700 EV, Wageningen, The Netherlands

Received 19 January 2009 ,Revised 4 May 2009 ,Accepted 8 May 2009.

References 

  1. Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJ, Moen CJ, Muller M, et al. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol. 2007;
  2. Ranheim T, Halvorsen B. Coffee consumption and human health — beneficial or detrimental? — Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and Type 2 diabetes mellitus. Mol Nutr Food Res. 2005;49(3):274–284
  3. Halvorsen B, Ranheim T, Nenseter MS, Huggett AC, Drevon CA. Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts. J Lipid Res. 1998;39(4):901–912
  4. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997;17:305–324
  5. Speer K, Kölling-Speer I. The lipid fraction of the coffee bean. Braz J Plant Physiol. 2006;18(1):201–216
  6. Weusten-Van der Wouw MP, Katan MB, Viani R, Huggett AC, Liardon R, Liardon R, et al. Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res. 1994;35:721–733
  7. Urgert R, Schulz AG, Katan MB. Effects of cafestol and kahweol from coffee grounds on serum lipids and serum liver enzymes in humans. Am J Clin Nutr. 1995;61(1):149–154
  8. de Roos B, Katan MB. Possible mechanisms underlying the cholesterol-raising effect of the coffee diterpene cafestol. Curr Opin Lipidol. 1999;10(1):41–45
  9. Urgert R, Essed N, van der Weg G, Kosmeijer-Schuil TG, Katan MB. Separate effects of the coffee diterpenes cafestol and kahweol on serum lipids and liver aminotransferases. Am J Clin Nutr. 1997;65(2):519–524
  10. Boekschoten MV, Hofman MK, Buytenhek R, Schouten EG, Princen HM, Katan MB. Coffee oil consumption increases plasma levels of 7alpha-hydroxy-4-cholesten-3-one in humans. J Nutr. 2005;135(4):785–789
  11. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol. 2002;40(8):1155–1163
  12. Higgins LG, Cavin C, Itoh K, Yamamoto M, Hayes JD. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein. Toxicol Appl Pharmacol. 2008;226(3):328–337
  13. Huber WW, Rossmanith W, Grusch M, Haslinger E, Prustomersky S, Peter-Vorosmarty B, et al. Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem Toxicol. 2008;46(4):1230–1238
  14. Huber WW, Scharf G, Nagel G, Prustomersky S, Schulte-Hermann R, Kaina B. Coffee and its chemopreventive components kahweol and cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver — comparison with phase II xenobiotic metabolism. Mutat Res. 2003;522(1-2):57–68
  15. Huber WW, Teitel CH, Coles BF, King RS, Wiese FW, Kaderlik KR, et al. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities. Environ Mol Mutagen. 2004;44(4):265–276
  16. Lee KJ, Choi JH, Jeong HG. Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol. 2007;45(11):2118–2125
  17. Wattenberg LW. Inhibition of neoplasia by minor dietary constituents. Cancer Res. 1983;43(5 Suppl):2448s–2453s
  18. Huber WW, Parzefall W. Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk. Methods Enzymol. 2005;401:307–341
  19. Huber WW, Prustomersky S, Delbanco E, Uhl M, Scharf G, Turesky RJ, et al. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol. Arch Toxicol. 2002;76(4):209–217
  20. Di Simplicio P, Jensson H, Mannervik B. Effects of inducers of drug metabolism on basic hepatic forms of mouse glutathione transferase. Biochem J. 1989;263(3):679–685
  21. Grubben MJ, Van Den Braak CC, Broekhuizen R, De Jong R, Van Rijt L, De Ruijter E, et al. The effect of unfiltered coffee on potential biomarkers for colonic cancer risk in healthy volunteers: a randomized trial. Aliment Pharmacol Ther. 2000;14(9):1181–1190
  22. Scharf G, Prustomersky S, Huber WW. Elevation of glutathione levels by coffee components and its potential mechanisms. Adv Exp Med Biol. 2001;500:535–539
  23. Huber WW, Scharf G, Rossmanith W, Prustomersky S, Grasl-Kraupp B, Peter B, et al. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol. 2002;75(11-12):685–694
  24. Boekschoten MV, Schouten EG, Katan MB. Coffee bean extracts rich and poor in kahweol both give rise to elevation of liver enzymes in healthy volunteers. Nutr J. 2004;3:7
  25. Alvarez-Diez TM, Zheng J. Detection of glutathione conjugates derived from 4-ipomeanol metabolism in bile of rats by liquid chromatography-tandem mass spectrometry. Drug Metab Dispos. 2004;32(12):1345–1350
  26. Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol. 2006;26(1):221–229
  27. Copple IM, Goldring CE, Kitteringham NR, Park BK. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology. 2008;246(1):24–33
  28. Boerboom AM, Vermeulen M, van der Woude H, Bremer BI, Lee-Hilz YY, Kampman E, et al. Newly constructed stable reporter cell lines for mechanistic studies on electrophile-responsive element-mediated gene expression reveal a role for flavonoid planarity. Biochem Pharmacol. 2006;72(2):217–226
  29. Klett EL, Lu K, Kosters A, Vink E, Lee MH, Altenburg M, et al. A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. BMC Med. 2004;2:5
  30. Balani SK, Zhu T, Yang TJ, Liu Z, He B, Lee FW. Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys. Drug Metab Dispos. 2002;30(10):1059–1062
  31. Yang KH, Choi YH, Lee U, Lee JH, Lee MG. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism. J Pharm Pharmacol. 2009;61(1):47–54
  32. Lee-Hilz YY, Boerboom AM, Westphal AH, Berkel WJ, Aarts JM, Rietjens IM. Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chem Res Toxicol. 2006;19(11):1499–1505
  33. de Roos B, Caslake MJ, Stalenhoef AF, Bedford D, Demacker PN, Katan MB, et al. The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects. Am J Clin Nutr. 2001;73(1):45–52
  34. De Roos B, Van Tol A, Urgert R, Scheek LM, Van Gent T, Buytenhek R, et al. Consumption of French-press coffee raises cholesteryl ester transfer protein activity levels before LDL cholesterol in normolipidaemic subjects. J Intern Med. 2000;248(3):211–216
  35. Urgert R, Weusten-van der Wouw MP, Hovenier R, Meyboom S, Beynen AC, Katan MB. Diterpenes from coffee beans decrease serum levels of lipoprotein(a) in humans: results from four randomised controlled trials. Eur J Clin Nutr. 1997;51(7):431–436
  36. Post SM, de Wit EC, Princen HM. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler Thromb Vasc Biol. 1997;17(11):3064–3070
  37. Chen LJ, DeRose EF, Burka LT. Metabolism of furans in vitro: ipomeanine and 4-ipomeanol. Chem Res Toxicol. 2006;19(10):1320–1329
  38. Khojasteh-Bakht SC, Chen W, Koenigs LL, Peter RM, Nelson SD. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide. Drug Metab Dispos. 1999;27(5):574–580
  39. Peterson LA, Cummings ME, Vu CC, Matter BA. Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial. Drug Metab Dispos. 2005;33(10):1453–1458
  40. Baer BR, Rettie AE, Henne KR. Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate. Chem Res Toxicol. 2005;18(5):855–864
  41. Cavin C, Mace K, Offord EA, Schilter B. Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells. Food Chem Toxicol. 2001;39(6):549–556
  42. Huber WW, Haslinger E, Schachner D, Parzefall W, Grasl-Kraupp B, Hochreiter A, et al. The carcinogen azonymethane causes necrosis and oxidative stress in rat liver within 48 hours after injection, a toxic effect that is however strongly mitigated by pretreatment with the coffee components kahweol and cafestol. Naunyn Schmiedebergs Arch Pharmacol. 2007;375(Suppl. 1):94
  43. Urgert R, Meyboom S, Kuilman M, Rexwinkel H, Vissers MN, Klerk M, et al. Comparison of effect of cafetiere and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial. BMJ. 1996;313(7069):1362–1366
  44. Falkner KC, Pinaire JA, Xiao GH, Geoghegan TE, Prough RA. Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. Mol Pharmacol. 2001;60(3):611–619
  45. Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol. 2002;62(3):638–646
  46. Tao KS, Wang W, Wang L, Cao DY, Li YQ, Wu SX, et al. The multifaceted mechanisms for coffee's anti-tumorigenic effect on liver. Med Hypotheses. 2008;71(5):730–736
  47. Surh YJ. NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr. 2008;17(Suppl 1):269–272
  48. Surh YJ, Na HK. NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr. 2008;2(4):313–317

☆ This work was supported by a grant of the TI Food & Nutrition.

PII: S0955-2863(09)00104-1

doi: 10.1016/j.jnutbio.2009.05.001

The Journal of Nutritional Biochemistry
Volume 21, Issue 8 , Pages 757-763 , August 2010

Article Tools

* Image Usage & Resolution